Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up study of THYR-008-00 thyroid cancer patients after remnant ablation
2005-004450-27Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thyrotropin alfa in thyroid cancer, sponsored by Sanofi. Primary endpoint: Confirmation of thyroid remnant ablation status. Started Jun 2006; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on 2005-004450-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004450-27.